Lee J S, Im J G, Ahn J M, Kim Y M, Han M C
Department of Radiology, College of Medicine, Seoul National University, Korea.
Radiology. 1992 Aug;184(2):451-4. doi: 10.1148/radiology.184.2.1620846.
To evaluate the prognostic implication of ground-glass attenuation at high-resolution computed tomography (HRCT) in assessing response to treatment in fibrosing alveolitis, the authors correlated HRCT findings with the improvement in pulmonary function, as represented by the increase in percentage predicted values on pulmonary function tests after corticosteroid therapy. Nineteen patients underwent HRCT before treatment and pulmonary function testing before and after treatment. The HRCT scans were reviewed by two independent observers. Areas of ground-glass attenuation were quantified subjectively by using a 0%-100% scale with 10% increments. The extent of ground-glass attenuation at HRCT was significantly correlated with improvement in diffusing capacity for carbon monoxide (r = .67, P = .0019), forced vital capacity (r = .71, P = .0007), and forced expiratory volume in 1 second (r = .64, P = .0034) after steroid treatment. These results suggest that ground-glass attenuation at HRCT is a good predictor of response to treatment in fibrosing alveolitis.
为了评估高分辨率计算机断层扫描(HRCT)上磨玻璃影在评估特发性肺纤维化治疗反应中的预后意义,作者将HRCT表现与肺功能改善情况进行了关联,肺功能改善情况以皮质类固醇治疗后肺功能测试预测值百分比的增加来表示。19例患者在治疗前接受了HRCT检查,并在治疗前后进行了肺功能测试。HRCT扫描由两名独立的观察者进行评估。使用0%-100%的量表主观量化磨玻璃影区域,增量为10%。HRCT上磨玻璃影的范围与类固醇治疗后一氧化碳弥散量的改善(r = 0.67,P = 0.0019)、用力肺活量(r = 0.71,P = 0.0007)和1秒用力呼气量(r = 0.64,P = 0.0034)显著相关。这些结果表明,HRCT上的磨玻璃影是特发性肺纤维化治疗反应的良好预测指标。